Illinois attorney general sues Insys over fentanyl drug marketing
Aug 25 (Reuters) - The Illinois attorney general on Thursday sued Insys Therapeutics Inc, accusing it of deceptively marketing and selling an addictive fentanyl-based medication, intended to treat cancer pain, to doctors for off-label uses.
Attorney General Lisa Madigan, whose office is investigating other opioid manufacturers for similar practices, said the lawsuit seeks to bar Insys from selling its products in Illinois and impose financial penalties on the company. (Reporting by Nate Raymond in New York; Editing by Chizu Nomiyama)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.
&)
&)
&)
&)
&)